Willow Biosciences

Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) reported record revenue of $1.2 million for fiscal 2023 as it executed collaborations during the year, including several partnerships which have positioned the company for continued growth in 2024. The company, which develops and produces precision fermented ingredients, said its full-year revenue increased by 43% from $821,000 in 2022. » Mehr auf proactiveinvestors.com

Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) announced that Kalsec, a leading global producer of food protection, colors, and advanced hop products for the food and beverage industry, has made a second strategic investment in the company. The company said this investment was connected to a previous one, where Kalsec committed to subscribe for an additional US$100,000 upon the completion of an operational milestone by Willow, which was completed on February 23, 2024. » Mehr auf proactiveinvestors.com

Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) has announced a strategic US$100,000 investment from Kalsec Inc to aid its development and commercialisation of natural food ingredients. Updating on Tuesday, Willow said the non-brokered private equity placement was expected to mark the first tranche of financing based on development milestones. » Mehr auf proactiveinvestors.com